Literature DB >> 32159362

Purinergic signalling, DAMPs and inflammation.

Francesco Di Virgilio1, Alba Clara Sarti1, Robson Coutinho-Silva2.   

Abstract

Danger sensing is one of the most fundamental evolutionary features enabling multicellular organisms to perceive potential threats, escape from risky situations, fight actual intruders and repair damage. Several endogenous molecules are used to "signal damage", currently referred to as "alarmins" or "Damage-Associated Molecular Patterns" (DAMPs), most being already present within all cells (pre-formed DAMPs), and thus ready to be released, and others neo-synthesized following injury. Over recent years it has become overwhelmingly clear that adenosine 5'-triphosphate (ATP) is a ubiquitous and extremely efficient DAMP (thus promoting inflammation) and its main metabolite, adenosine, is a strong immunosuppressant (thus dampening inflammation). Extracellular ATP ligates and activates the P2 purinergic receptors (P2Rs) and is then degraded by soluble and plasma membrane ecto-nucleotidases to generate adenosine acting at P1 purinergic receptors (P1Rs). Extracellular ATP, P2Rs, ecto-nucleotidases, adenosine and P1Rs are basic elements of the purinergic signalling network and fundamental pillars of inflammation.

Entities:  

Keywords:  adenosine; extracellular ATP; inflammation

Year:  2020        PMID: 32159362     DOI: 10.1152/ajpcell.00053.2020

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  41 in total

1.  P2X7R: pivotal player in sepsis-induced liver damage.

Authors:  Marta Vuerich
Journal:  Purinergic Signal       Date:  2021-01-18       Impact factor: 3.765

Review 2.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

Review 3.  The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets.

Authors:  André Campos de Lima; Lucas Macedo Chaves; Samantha Nuncio Prestes; Aline Mânica; Andreia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-06-01       Impact factor: 6.986

Review 4.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

Review 5.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

6.  High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice.

Authors:  Gonzalo Jorquera; Roberto Meneses-Valdés; Giovanni Rosales-Soto; Denisse Valladares-Ide; Cristian Campos; Mónica Silva-Monasterio; Paola Llanos; Gonzalo Cruz; Enrique Jaimovich; Mariana Casas
Journal:  Diabetologia       Date:  2021-03-12       Impact factor: 10.122

7.  Extracellular ectonucleotidases are differentially regulated in murine tissues and human polymorphonuclear leukocytes during sepsis and inflammation.

Authors:  Clarissa B Haas; Marianna Lovászi; Pál Pacher; Priscila Oliveira de Souza; Julie Pelletier; Rafael Olive Leite; Jean Sévigny; Zoltán Németh; Elizandra Braganhol; György Haskó
Journal:  Purinergic Signal       Date:  2021-10-04       Impact factor: 3.765

Review 8.  TSPO protein binding partners in bacteria, animals, and plants.

Authors:  Carrie Hiser; Beronda L Montgomery; Shelagh Ferguson-Miller
Journal:  J Bioenerg Biomembr       Date:  2021-06-30       Impact factor: 2.945

9.  Physiology of Cultured Human Microglia Maintained in a Defined Culture Medium.

Authors:  Manju Tewari; Maheen Khan; Megha Verma; Jeroen Coppens; Joanna M Kemp; Richard Bucholz; Philippe Mercier; Terrance M Egan
Journal:  Immunohorizons       Date:  2021-04-30

Review 10.  Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Authors:  Peter Illes; Christa E Müller; Kenneth A Jacobson; Thomas Grutter; Annette Nicke; Samuel J Fountain; Charles Kennedy; Günther Schmalzing; Michael F Jarvis; Stanko S Stojilkovic; Brian F King; Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2020-12-21       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.